MEDXF Stock Price, Chart, Stats & News

Medexus Pharmaceuticals Inc.
Save
Medexus Pharmaceuticals Inc. (MEDXF) does not currently pay a dividend.
116.83M
Market cap
–
Current P/E
23.58x
Forward P/E
MEDXF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, including cancer treatment (oncology), blood disorders (hematology), joint and muscle conditions (rheumatology), autoimmune disorders, and allergic reactions. Among its leading offerings are Rasuvo and Metoject, both methotrexate formulations specifically developed for managing rheumatoid arthritis and various autoimmune conditions.
Similar securities
Based on sector and market capitalization
Report issue





